Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) once daily (OD) for 24 weeks in persistent asthma

被引：0
|
作者：
O'Byrne, Paul M. [1 ]
Bleecker, Eugene R. [2 ]
Bateman, Eric D. [3 ]
Busse, William W. [4 ]
Woodcock, Ashley [5 ]
Forth, Richard [6 ]
Toler, Tom [7 ]
Jacques, Loretta [8 ]
Lotvall, Jan [9 ]
机构：
[1] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[2] Wake Forest Univ Hlth Sci, Ctr Genom & Personalized Med, Winston Salem, NC USA
[3] Univ Cape Town, Dept Med, Rondebosch, South Africa
[4] Univ Wisconsin, Dept Med, Madison, WI USA
[5] Univ Manchester, Sch Translat Med, Manchester, Lancs, England
[6] GlaxoSmithKline, Quantitat Sci Div, Res Triangle Pk, NC USA
[7] GlaxoSmithKline, Resp Med Dev Ctr, Res Triangle Pk, NC USA
[8] GlaxoSmithKline, Resp Med Dev Ctr, Uxbridge, Middx, England
[9] Univ Gothenburg, Krefting Res Ctr, Gothenburg, Sweden
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Treatments; Asthma; -; management;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3151
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effect of fluticasone furoate (FF)/vilanterol (VI) once daily (OD) on risk of severe exacerbations in asthma
    Bateman, Eric D.
    O'Byrne, Paul M.
    Busse, William W.
    Lotvall, Jan
    Bleecker, Eugene R.
    Andersen, Leslie
    Haumann, Brett
    Frith, Lucy
    Lim, Jessica
    Jacques, Loretta
    Woodcock, Ashley
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Efficacy and safety of once-daily (OD) fluticasone furoate (FF) 50mcg over 24 weeks in adults and adolescents with persistent asthma
    Busse, William W.
    Bateman, Eric D.
    O'Byrne, Paul M.
    Lotvall, Jan
    Woodcock, Ashley
    Medley, Hilary
    Forth, Richard
    Jacques, Loretta
    Bleecker, Eugene R.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [3] Efficacy and safety of once-daily (OD) fluticasone furoate (FF) in patients with persistent asthma: A 24-week randomised trial
    Lotvall, Jan
    Bleecker, Eugene
    Busse, William
    O'Byrne, Paul
    Woodcock, Ashley
    Bateman, Eric
    Kerwin, Edward
    Stone, Sally
    Forth, Richard
    Jacques, Loretta
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [4] Efficacy of fluticasone furoate (FF) as a monotherapy and in combination with vilanterol (VI) over 12 weeks in patients with persistent asthma
    Bleecker, Eugene R.
    Lotvall, Jan
    O'Bryne, Paul M.
    Woodcock, Ashley
    Busse, William W.
    Forth, Richard
    Medley, Hilary
    Nunn, Carol
    Jacques, Loretta
    Bateman, Eric D.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [5] Efficacy and safety of once-daily (OD) fluticasone furoate (FF) in adults and adolescents with moderate-to-severe persistent asthma
    Woodcock, Ashley
    Lotvall, Jan
    Bleecker, Eugene R.
    Busse, William W.
    O'Byrne, Paul M.
    Bateman, Eric D.
    Stone, Sally
    Ellsworth, Anna
    Jacques, Loretta
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [6] Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) compared with fluticasone propionate/salmeterol combination (FP/SAL) in adults and adolescents with persistent asthma
    Woodcock, Ashley
    Bleecker, Eugene R.
    Lotvall, Jan
    O'Byrne, Paul M.
    Bateman, Eric D.
    Medley, Hilary
    Ellsworth, Anna
    Jacques, Loretta
    Busse, William W.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [7] Efficacy and safety of Once-Daily Vilanterol/Fluticasone furoate MDI in persistent asthma: Phase 3 OD-INHALE Study
    Kumar, Avdhesh
    Jain, Manish Kumar
    Barge, Vijaykumar Bhagwan
    Kumar, Raghumanda Sunil
    Gupta, Neeraj
    Yadav, Harendra
    Pal, Amitava
    Redkar, Vivek Eknath
    Mondal, Asish
    Rathore, Rahul Kumar
    Daultani, Pavankumar
    Jaiswal, Ashok
    Mehta, Ravi T.
    JOURNAL OF ASTHMA, 2024, 61 (10) : 1181 - 1189
  • [8] Efficacy of fluticasone furoate (FF) and vilanterol (VI), separately and in combination (FF/VI), in an allergen challenge model
    Oliver, Amanda
    Bjermer, Leif
    Quinn, Dean
    Saggu, Parminder
    Thomas, Paul
    Yarnall, Katy
    Lotvall, Jan
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [9] Efficacy of fluticasone furoate (FF)/vilanterol (VI) or FF alone in asthma patients with differing eosinophil (eos) levels
    Woodcock, Ashley
    Jacques, Loretta
    Leather, David
    Forth, Richard
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Safety and tolerability of the novel inhaled corticosteroid (ICS) fluticasone furoate (FF) in combination with the long-acting beta2 agonist (LABA) vilanterol (VI) administered once daily (OD) in patients with asthma
    Busse, William W.
    O'Byrne, Paul M.
    Bleecker, Eugene R.
    Lotvall, Jan
    Woodcock, Ashley
    Andersen, Leslie
    West, Jody
    Jacques, Loretta
    Apoux, Ludovic
    Bateman, Eric D.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345